PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biomedicine and Prevention, \'Tor Vergata\' University of Rome, 00133, Rome, Italy. novelli@med.uniroma2.it.\', \'IRCCS Neuromed, Pozzilli, IS, Italy. novelli@med.uniroma2.it.\', \'Department of Pharmacology, School of Medicine, University of Nevada, Reno, NV, 89557, USA. novelli@med.uniroma2.it.\', \'Department of Biology, Tor Vergata University of Rome, 00133, Rome, Italy.\', \'Pediatric Hemato-Oncology, Sheba Medical Center, Tel Hashomer, Israel.\', \'Department of Biomedicine and Prevention, \'Tor Vergata\' University of Rome, 00133, Rome, Italy.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.\', \'Department of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, 06510, USA.\', \'Haematology, Muhimbili University of Health and Allied Sciences, Dar-es Salaam, Tanzania.\', \'Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, Queensland, 4878, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s40246-021-00326-3
?:doi
?:hasPublicationType
?:journal
  • Human genomics
is ?:pmid of
?:pmid
?:pmid
  • 33966626
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.501
?:rankingScore_hIndex
  • 43
?:title
  • COVID-19 one year into the pandemic: from genetics and genomics to therapy, vaccination, and policy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all